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Early in an immune response, B cells 
latch on to antigens embedded in the 
surface membranes of follicular den-
dritic cells and macrophages. Engage-
ment with antigen spurs a flurry of 
activity at the point of contact on the B 
cell surface—a phenome-
non that Facundo Batista 
is documenting in molec-
ular detail.
During his post-doc-
toral research, Batista dis-
covered that B cell 
receptors (BCRs) must ex-
ceed an affinity threshold 
to trigger B cell activation 
(1). He also found that B 
cells form an organized 
molecular structure, known as an immu-
nological synapse, when they encounter 
membrane-tethered antigen. BCRs ac-
cumulate antigens at the synapse, then 
extract and internalize them for subse-
quent presentation to T cells (2).
After Batista set up his own labora-
tory at the London Research Institute, 
he began to follow these events in real 
time. His studies revealed that anti-
gen-bound B cells reorganize their ac-
tin cytoskeleton to first spread across 
the surface of the antigen presenting 
cell and then to contract their mem-
branes, concentrating the antigen at 
the synapse within a ring of adhesion 
molecules (3). High affinity antigens 
induce more spreading than low affin-
ity antigens, leading to increased anti-
gen capture.
Using a mathematical model based 
on this data, Batista’s group hypothe-
sized that deactivating the spreading 
mechanism would prevent cells from 
distinguishing between high and low af-
finity antigens—a prediction confirmed 
by their later experiments with spread-
ing-defective B cells. The group has 
since identified the signaling molecules 
and pathways that enhance B cell adhe-
sion at the synapse and contribute to ac-
tivation (4–6). They have now begun to 
use multi-photon microscopy tech-
niques to image B cell behavior in real 
time in living tissue.
A NOBEL INSPIRATION
How did your journey into science begin?
Growing up in Argentina, I was really 
into things that involved nature and 
biology, and wanted to make docu-
mentaries about the Antarctic and 
things like that. But my interests 
changed when I started undergraduate 
studies at the University of Buenos Aires. 
I heard two professors, Daniel Gold-
stein and Alberto Kornblihtt, lecture 
on their research in molecular biology 
and I was hooked.
How did you end up earning a PhD in 
immunology from a program in Italy?
Ever since the military started to perse-
cute university professors and other free 
thinkers in the 1960s, there was always 
a wave of scientists leaving the country. 
I came of age much later of course, but I 
also wanted to go abroad to study, as 
many of my friends were doing. So I 
took the necessary exams and was ac-
cepted at the International Center for 
Genetic Engineering and Biotechnology 
in Trieste, Italy.
At the time, I became interested in 
immunology because of César Milstein—
an Argentinean scientist who won the 
Nobel Prize for his research on mono-
clonal antibodies. Inspired by his work, I 
joined Oscar Burrone’s laboratory to 
work on the assembly of immunoglobu-
lin E isoforms on the B cell surface.
ATTRACTED BY AFFINITY
Why did you move to England for post-
doctoral work?
After I fi  nished my PhD, I wanted to 
work on B cell activation, a fi  eld  in 
which Michael Neuberger was doing 
brilliant work. I got a European Mo-
lecular Biology Laboratory (EMBL) 
fellowship to work in his laboratory in 
Cambridge for fi  ve years. Michael re-
ally shaped my attitude toward research 
by showing me how to think about sci-
ence and ask questions that were wider 
in scope.
What problem did you work on in 
Michael’s laboratory?
I was trying to understand how the af-
fi  nity of interaction between the BCR 
and antigen impacted B cell activation. 
We fi rst studied this issue using soluble 
antigens. We found that there was a min-
imum affi   nity threshold to activate the 
BCR and that the cells are very good at 
discriminating between affi   nities that are 
in the lower range. But the capacity of 
B cells to discriminate between higher 
range affi     nities is not so good, which 
suggests there is a “ceiling” during affi   n-
ity maturation.
BECOMING DYNAMIC
How did you end up working on the 
immunological synapse?
During my post-doc, I came across the 
work of Mike Dustin and others who 
were working on immunological syn-
apses in T cells. Their papers made me 
think that B cells in lymph nodes might 
mainly recognize antigens on surfaces of 
other cells, as this could refl  ect a more 
physiological means of antigen-induced 
B cell activation. Michael and I showed 
that B cells also form synapses after anti-
gen encounter.
What was your next step?
The studies I did with Michael were 
very interesting, but they were limited 
by their static nature. So when I set up 
Batista combines high resolution imaging techniques with mathematical modeling 
to identify the molecules and mechanisms that B cells use to recognize antigens.
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my laboratory, I wanted to carry out dy-
namic studies of B cell antigen recogni-
tion. I called Mike Dustin, whom I’d 
never met, as he had developed a tech-
nique involving artifi  cial bilayers to ana-
lyze T cell interactions. Mike kindly al-
lowed me to learn these techniques in 
his laboratory. We have since modifi  ed 
and developed this method specifi  cally 
for analyzing B cell interactions.
What’s the advantage of this technique?
We can put specifi  c ligands at any con-
centration onto lipid bi-layers on glass 
cover-slips. This gives us a unique fo-
cal plane for microscopy and allows us 
to be very quantitative about the in-
formation we get when cells bind to 
these ligands. The system allows us to 
study isolated receptors or the coopera-
tion between two or more receptors 
or their interaction with other surface 
molecules. We used this system to 
show that B cells are better at recog-
nizing low affi   nity antigens thanks to 
the activity of adhesion molecules 
such as LFA-1 on the B cell surface, 
which aid cell attachment and allow 
sampling of a greater area of the antigen-
presenting surface.
How did you discover membrane 
spreading and contraction?
We realized that after initial antigen 
contact, it took ∼10 min for the syn-
apse to form. So we started to look 
more closely at what was happening at 
the surface during these early moments. 
My student Sebastian Fleire wanted to 
look at the cells interacting with antigens 
using electron microscopy. I thought the 
idea was rubbish because I didn’t think 
he would see any-
thing interesting 
that way. But he 
came back with 
these amazing pic-
tures; I never 
thought the spread-
ing process would 
be so dramatic. And 
what was more in-
teresting was that 
this process was 
driven by the cell’s 
cytoskeleton. The 
B cell cytoskeleton has very much 
been ignored over the years, but not 
anymore.
MICROCLUSTERS AND 
MODELING
How does the cytoskeleton drive signaling?
The powerful combination of artifi  cial 
lipid bilayers and total internal refl  ection 
microscopy showed us that cells poly-
merize actin and form surface microclus-
ters of BCR and antigen as they spread. 
BCR engagement triggers the activa-
tion of a small GTPase called Rac2, 
which in turn activates the adhesion 
molecule LFA-1—so this is a form of 
inside-out signaling that increases B cell 
adhesion. Antigen binding also initiates 
the recruitment of other positive regula-
tors such as CD19, which is critical for 
B cell activation in vivo. The microclus-
ters thus form a platform for the assem-
bly of all these molecules into what 
we’ve named “microsignalosomes”.
Some molecules, such as CD19, are 
dynamically recruited to the BCR. 
Other bulkier molecules such as CD45 
are excluded. This size-dependent ex-
clusion fits the “kinetic-segregation” 
mechanism postulated by Anton van der 
Merwe and colleagues.
Are the surface changes that occur after 
activation diff  erent between naive cells 
and memory cells? And how do BCR 
signals compare with signals originating 
from cytokine receptors such as those that 
bind BAFF?
Those are very good questions that we 
plan to address in the future. It’s possible 
that immune memory translates into cy-
toskeletal memory; memory cells might 
recruit a diff  erent subset of signaling mol-
ecules. As for cytokine signals, we have 
yet to integrate them into the picture.
Are you also looking at these phenomena 
in vivo?
Yes. Yolanda Carrasco, one of my very 
talented post-docs, recently used two-
photon microscopy to track antigen in 
vivo, and identifi  ed  the 
precise area in the lymph 
nodes where B cells ac-
quire particulate antigen. 
We’re now trying to im-
prove the resolution at 
which we can study this 
interaction. I’ve realized 
that it’s one thing to buy 
a fancy microscope, but 
the key is to develop 
techniques to use it in 
the most eff  ective  way 
and push the limits of what we can use it 
for. I’ve started to do this by bringing 
people who are experts in microscopy 
and physics into my group.
How does mathematical modeling come 
into play in your work?
Our collaboration with Dennis Bray en-
abled us to appreciate the importance of 
mathematical modeling. The beauty of 
modeling is that we can answer questions 
about things we’ve yet to test biologically. 
We can include more parameters and get 
faster answers. This method pointed us to-
ward the fact that a cell that will not be 
able to spread and contract will not be 
able to sense diff  erences in ligand affi   nity.
Modeling is often criticized because 
people question the in vivo relevance of 
the data we get. For me, both approaches 
(theoretical and experimental) are essen-
tial and valid because we only learn 
more when a process that’s been studied 
in vivo is revisited in a quantitative way, 
and vice versa.
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B cells that can spread (left) collect more antigens than B cells that 
can’t (right).
“The beauty of 
modeling is 
that we can 
answer 
questions about 
things we've 
yet to test 
biologically.”